Greece
RTsafe, a Greek medical technology company established in 2014, is revolutionizing quality assurance in radiotherapy. By integrating expertise in medical physics with precision 3D printing technology, RTsafe produces anatomically accurate pseudo-in-vivo dosimetry phantoms. These models facilitate end-to-end commissioning, benchmarking, and patient-specific quality assurance across various applications such as SRS, IMRT, VMAT, and SBRT.
The company's vision is to simulate every radiotherapy intervention on personalized phantoms before patient treatment, thereby significantly enhancing safety and treatment efficacy. RTsafe benefits multiple stakeholders—allowing medical professionals to devise meticulously precise treatment plans while aiding the radiotherapy industry in refining its technology.
Its last funding round was a $1.00M Convertible Note in March 2019, secured from notable investors such as VentureFriends and Simanta Das. Operating within the Health Care and Medical Devices industries, RTsafe stands as a promising proposition for investors seeking innovative solutions in medical safety and accuracy.
MVision AI